Analytical goals for the performance characteristics of assays of haemaoglobin A1c (HbA1c) have been investigated using different assumptions for generation of estimates, these being based on strategies using data on biological variation and on the clinical use of results. The derived goals are highly dependent on the assumptions made. In general, in monitoring of patients (using results from the same laboratory), the analytical imprecision is the most demanding, whereas bias (inaccuracy) is the most important characteristic when strategies for several centres (laboratories) to achieve similar results are invoked. Goals for analytical quality should be given in a form in which both analytical imprecision and bias (or systematic error) are specified. When several goals are to be considered (for different relevant assumptions), the most demanding should be used.
SvendsenPAALauritzenTSøegaardUNerupJ. Glycosylated hemoglobin and steady-state mean blood glucose concentrations in type 1 (insulin dependent) diabetes. Diabetologia1982; 23: 403–5.
2.
BoucherBJBurrinJMGouldBJA collaborative study of measurements of glycated hemoglobin in several methods in several laboratories in the United Kingdom. Diabetologia1983; 24: 265–71.
3.
JohnWG. Glycated hemoglobin analyses-assessment of within and between-laboratory performance in a large UK region. Ann Clin Biochem1987; 24: 453–60.
4.
BaynesJWBunnHFGoldsteinDHarrisMMartinDBPetersonCWintherhallerK. National Diabetes Data Group: Report of the Expert Committee on Glucosylated Hemoglobin. Diabetes Care1984; 7: 602–6.
5.
TonksDB. A study of the accuracy and precision of clinical chemistry determinations in 170 Canadian laboratories. Clin Chem1963; 9: 217–33.
6.
BarnettRN. Medical significance of laboratory results. Am J Clin Pathol1968; 50: 671–6.
7.
CotloveEHarrisEKWilliamsGZ. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. III. Physiological and medical implications. Clin Chem1970; 16: 1028–32.
8.
HarrisEK. A theoretical basis for monitoring through proficiency testing the clinical relevance of a laboratory test. Influence of target use on tolerable inaccuracy. Arch Pathol Lab Med1988; 112: 416–20.
9.
GowansEMSHyltoftPetersen PBlaabjergOHørderM. Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. Scand J Clin Lab Invest1988; 48: 757–64.
10.
HyltoftPetersen PGowansEMSBlaabjergOHørderM. Analytical goals for the estimation of non-Gaussian reference intervals. Scand J Clin Lab Invest1989; 49: 727–37.
11.
Elion-GerritzenWE. Analytic precision in clinical chemistry and medical decisions. Am J Clin Pathol1980; 73: 183–95.
12.
SkendzelLPBarnettRNPlattR. Medically useful criteria for analytical performance of laboratory tests. Am J Clin Pathol1985; 83: 200–5.
13.
RossJWTholenDW. Optimizing clinical laboratory analytic accuracy: An historical perspective, system analysis and model of clinical utility. In: HowanitzPJ, ed. Quality Assurance in Physician Office, Bedside and Home Testing.Skokie, Illinois: College of American Pathologists1987; 85–125.
14.
RossJW. A theoretical basis for clinically relevant proficiency testing evaluation limits: Sensitivity analysis of method error, and preanalytic and postanalytic distribution of diagnostic variables. Arch Pathol Lab Med1988; 112: 421–34.
15.
HarrisEK. Statistical principles underlying analytic goal-setting in clinical chemistry. Am J Clin Pathol1979; 72: 374–82.
16.
FraserCG. Desirable standards of performance for therapeutic drug monitoring. Clin Chem1987; 33: 387–9.
17.
FraserCGBrowningMCK. Deciding the optimum interval between specimen collections: Theory and nomograms. Clin Chem1987; 33: 1436–8.
18.
HørderM, ed. Assessing Quality Requirements in Clinical Chemistry. The Nordic Clinical Chemistry Project (NORDKEM). Helsinki: Finnish Government Printing Center, 1980.
19.
HyltoftPetersen PHørderM. Ways of assessing quality goals for diagnostic tests in clinical situations. Arch Pathol Lab Med1988; 112: 435–43.
20.
Nørregaard-HansenKHyltoftPetersen PHangaardJSimonsenEERasmussenOHørderM. Early observations of S-myoglobin in the diagnosis of acute myocardial infarction. The influence of discrimination limit, analytical quality, patient's sex and prevalence of disease. Scand J Clin Lab Invest1986; 46: 561–9.
21.
AntonsenSQuistN. Evaluating blood leucocytes, blood neutrophils and plasma elastase in acute appendicitis. Theor Surg1988; 3: 17–22.
22.
GrothTLLjunghallSdeVerdierC-H. Optimal screening for patients with hyperparathyroidism with use of serum calcium observations. A decision-theoretical analysis. Scand J Clin Lab Invest1983; 43: 699–707.
23.
ElevitchFR (ed). Analytical Goals in Clinical Chemistry. CAP Aspen Conference, 1976. Skokie, Illinois: College of American Pathologists, 1977.
FraserCG. The application of theoretical goals based on biological variation in proficiency testing. Arch Pathol Lab Med1988; 112: 404–15.
26.
FraserCGHarrisEK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci1989; 27: 409–30.
27.
FraserCG. Analytical goals for the monitoring of healthy individuals. In: HarrisEKYasakaT, eds. Maintaining a Healthy State within the Individual.Amsterdam: Elsevier1987; 137–45.
28.
HyltoftPetersen PLytkenLarsen MHørderM.Prerequisites for the maintenance of a certain state of health by biochemical monitoring. In: HarrisEKYasakaT, eds. Maintaining a Healthy State within the Individual.Amsterdam: Elsevier1987; 147–58.
29.
LytkenLarsen MBlaabjergOHyltoftPetersen PHansenHHørderM. Analytical goal setting prior to selection of a method for glycated haemoglobin. Scand J Clin Lab Invest1990; 50: 715–21.
MogensenCE. Management of diabetic renal involvement and disease. Lancet1988; i: 867–70.
34.
AlbertiKGMMGriesFA. Management of non-insulin dependent diabetics in Europe: A Consensus view. Diabetic Medicine1988; 5: 275–81.
35.
Beck-NielsenHDamsgaardEMFaberOSchønau JørgensenFSchwartzSørensen N.Non-insulin dependent diabetes mellitus. Diagnosis and treatment. An explanatory report. Ugeskr Laeger1990; 152: 2–10.
36.
FraserCG. The necessity of achieving good laboratory performance. Diabetic Medicine1990; 7: 490–3.
37.
GowansEMSFraserCGHyltoftPetersen P.A guide to the use of probit transformation of Guassian distributions. Biochim Clin1989; 13: 327–36.
38.
FraserCGHyltoftPetersen PLytkenLarsen M.Setting analytical goals for random analytical error in specific clinical monitoring situations. Clin Chem1990; 36: 1625–8.
39.
WestgardJOBarryPL. Cost-effective Quality Control; Managing the Quality and Productivity of Analytical Processes.Washington: AACC, 1986.
40.
WestgardJOGrothT. Power functions for statistical control rules. Clin Chem1979; 25: 863–9.
41.
deVerdierC-HAronssonTNybergA, eds. Quality Control in Clinical Chemistry-Efforts to Find an Efficient Strategy. The Nordic Clinical Chemistry Project (NORDKEM). Helsinki: Finnish Government Printing Center, 1984.
